Sumitomo Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. The company is headquartered in Osaka, Osaka-Fu and currently employs 3,832 full-time employees. The firm operates through three geographical segments. The Japan segment is engaged in the manufacture, purchase, and sale of prescription drugs, purchase and sale of medical devices, undertakes development and manufacture in the field of regenerative medicine and cellular medicine, and the manufacture of pharmaceuticals, medical devices, and regenerative medicine products that have been developed through joint development in the field of regenerative medicine. This segment also provides storage and delivery service of pharmaceuticals. The North America segment is engaged in the manufacture, purchase, and sale of prescription drugs. The Asia segment is engaged in the manufacture and sale of prescription drugs (small packaging), and the import, purchase and sale of prescription drugs in Southeast Asia and Taiwan, as well as the provision and collection of information on products.
Sumitomo Pharma Co., Ltd. Información sobre dividendos
Sumitomo Pharma Co., Ltd. tiene un dividendo anual de 0.0076 por acción, con un rendimiento del 0.00%. El dividendo se paga semestralmente y la última fecha ex-dividendo fue Mar 30, 2023.
Rendimiento de dividendos
Dividendo anual
Fecha de ex-dividendos
0.00%
$0.0076
Mar 30, 2023
Frecuencia de pago
Relación de pago
Semestralmente
0.00%
Historial de dividendos
Fecha de ex-dividendos
Monto en efectivo
Fecha de Registro
Fecha de Pago
Mar 30, 2023
$7.00
Mar 31, 2023
Jun 28, 2023
Sep 29, 2022
$14.00
Sep 30, 2022
Dec 1, 2022
Mar 30, 2022
$14.00
Mar 31, 2022
Jun 24, 2022
Sep 29, 2021
$14.00
Sep 30, 2021
Dec 1, 2021
Mar 30, 2021
$14.00
Mar 31, 2021
Jun 25, 2021
Sep 29, 2020
$14.00
Sep 30, 2020
Dec 1, 2020
Gráficos de dividendos
DNPUF Dividendos
DNPUF Crecimiento de Dividendos (YoY)
Follow-Up Questions
¿Cuál es el dividendo actual pagado por Sumitomo Pharma Co., Ltd. y su dividendo anual?
¿Cuál es el ratio de pago de dividendos de Sumitomo Pharma Co., Ltd.?